Citation : 2015 Latest Caselaw 3707 Del
Judgement Date : 7 May, 2015
*IN THE HIGH COURT OF DELHI AT NEW DELHI
% Date of decision: 7th May, 2015
+ W.P.(C) No.2867/2014
THE DELHI NETWORK OF POSITIVE PEOPLE ... Petitioner
Through: Mr. Anand Grover, Sr. Adv. with Mr.
Saurabh Chauhan, Mr. Varun Jain &
Ms. Apurba Kundu, Advs.
Versus
UNION OF INDIA & ORS. .. Respondents
Through: Mr. Vikram Jetley, Adv. with Ms.
Chitra, Adv. for UOI.
CORAM :-
HON'BLE THE CHIEF JUSTICE
HON'BLE MR. JUSTICE RAJIV SAHAI ENDLAW
RAJIV SAHAI ENDLAW, J.
1. The petitioner has filed this petition under Article 226 of the Constitution
of India, as a Public Interest Litigation (PIL), to secure the rights of persons
living with HIV/AIDS, pleading, (i) that in or around mid-1990s it was
discovered that certain medicines i.e. anti-retrovirals (ARVs) when taken in
combination of three ARVs, can help treat HIV; (ii) however these medicines
were patented in several countries and the patent-holding pharmaceutical
companies were charging exorbitant prices thereof, which millions of people
living with HIV/AIDS in developing and least developed countries were unable
to afford; (iii) around the year 2001, Indian generic pharmaceutical companies
offered to make the same medicines at much lower costs and which resulted in
fall in the prices of the said medicines and which in turn enabled the developing
and least developed countries to provide treatment to persons living with
HIV/AIDS; (iv) however, the pharmaceutical companies adopted inter alia the
practice of filing multiple patent applications relating to a single medicine to
put the said medicines out of reach of the people living with HIV/AIDS; (v) in
a bid to limit the multiple patenting of medicines and to ensure that medicines
remain unpatented, the petitioner has been filing pre and post grant oppositions
to oppose patent applications relating to ARVs and other medicines of interest
and the petitioner has successfully opposed patent applications for ARVs,
helping to keep them off patent; (vi) while doing so, the petitioner noticed
another practice adopted by pharmaceutical companies to keep the patent
applications pending i.e. of filing a divisional patent application based on an
earlier filed patent application - this helps keep a patent application over a
particular medicine alive and creates uncertainty over the patent status of the
medicines; such uncertainty is against public interest; to remedy the same, the
present writ petition has been filed; (vii) Section 16 (1) of the Patents Act, 1970
enables a person who has made an application for a patent to, at any time
before the grant of patent, if he so desires, or with a view to remedy the
objection raised by the Controller on the ground that the claims of the complete
specification relate to more than one invention, file a further application in
respect of an invention disclosed in the provisional or complete specification
already filed in respect of the first mentioned application; (viii) however
Section 10(5) of the Act requires that the claims of a complete specification
must relate to a single invention, or in case of a group of inventions, to a single
inventive concept; (ix) that thus an application containing a claim of complete
specification relating to more than one invention is not a proper patent
application and liable to be rejected on this ground alone; however the remedy
of correcting the application is available to the applicants under Section 16 of
the Act; (x) however the concerned pharmaceutical companies/persons, with
the intent to keep their patent applications alive and/or to revive the patent
applications which were about to be rejected/refused, are misusing the system
of filing divisional application with claim which are identical to the claims of
the parent application; (xi) an analysis of prosecution history of the parent
applications shows that the divisional applications were filed after the Patent
Examiners had raised objections to the claims of the parent application and
suffer an order of deem abandonment of the parent application while keeping
the fresh application filed as a divisional application alive; (xii) due to the
aforesaid conduct of patent applicants, the petitioner has been constrained to
file pre-grant oppositions under Section 25(1) of the Act to at least two
divisional applications arising from one single parent application with claims
identical to those in parent application; (xiii) that Section 16 of the Patent Act is
intended to protect genuine inventors who disclose multiple inventions in a
single application but is being abused; (xiv) that the aforesaid abuse also results
in burden of repeated examination of patent application containing the very
same claims that had been reviewed earlier and a consequent wastage of
resources and time of the Patent Office; and, (xv) that though the petitioner
represented to the respondents Union of India, Controller General of Patents
and Joint Controller of Patents & Designs in this regard and whereafter the
Patents Rules were amended, but without addressing the issue .
Accordingly this petition has been filed seeking, (a) a direction to the
respondent no.1 Ministry of Industry and Commerce to prevent abuse of
process in filing of divisional patent applications, including by amending
Form-I of the Patents Act, to require a declaration from the patent applicant at
the time of filing such divisional application that the parent application
discloses multiple inventions not constituting one single inventive concept and
that the claims of the divisional applications are not identical to that of the
parent applications; (b) a prohibition against the respondent no.2 Controller
General of Patents and respondent no.3 Joint Controller of Patents & Designs
from proceeding with examining and processing divisional patent applications
on merits until the existence of jurisdictional fact and their maintainability as
divisional patent applications are first determined; (c) a direction to the
respondent no.2 Controller General of Patents to reject in limine all divisional
applications with claims identical to that of the parent applications, without
hearing the applicant on substantive issues of patentability; (d) a direction to
the respondent no.2 Controller General of Patents to identify patent applicants
who have abused the process and take action against them; and, (e) a direction
to the respondent no.2 Controller General of Patents and respondent no.3 Joint
Controller of Patents & Designs to ensure that in every patent application there
is an undertaking that there is no other application filed in respect of the same
inventive concept and in the event of the divisional applications to decide
without issuing notice whether claim is related to same inventive concept and if
so, to reject such an application.
2. The petition was entertained. An affidavit has been filed by the Assistant
Controller of Patents & Designs, Government of India stating, (i) that there is
no provision in the Act that prohibits any person from filing the division
application in the Patent Office; (ii) that under Section 11B, when a request for
examination is made in respect of any patent application, the same is referred
by Controller of Patents to an Examiner of Patents & Designs for making
report and the issue of allowability or refusal of said application is considered
based on the report of the said examination; (iii) that the amendments already
carried out to the Patents Rules pursuant to the representation of the petitioner
are sufficient to address the concern of the petitioner; (iv) action has also been
initiated with respect to the specific complaints filed by the petitioner; and, (v)
that of the 17 divisional patent applications, 16 have been either refused or
abandoned or withdrawn and only one divisional patent application had
proceeded to grant of patent.
3. The petitioner has filed a rejoinder reiterating its case.
4. We have heard the senior counsel for the petitioner.
5. As would be obvious from the above, the petition does not challenge any
provision of the Act or the Rules made thereunder and admits that the
procedure being followed, though abused by the errant patent applicants, is in
accordance with the Act and the Rules. The petitioner wants us to prevent the
abuse. However that, even according to the petitioner, would be possible only
by amending the Rules or by this Court issuing directions to the respondents to,
while dealing with the patent applications, act in a manner not provided for or
contrary to the Rules and which is beyond our jurisdiction.
6. We, in exercise of our power of judicial review, cannot legislate or even
give direction to legislate. The Act, vide Section 159 thereof empowers the
Central Government, to by notification in official gazette, make rules for
carrying out the purpose of the Act, particularly to provide the form and
manner in which any application for patent may be filed in the Patent Office
and the details to be furnished by the applicant to the Controller etc. Though
Section 158 empowers the High Courts also to make rules but only as to the
conduct and procedure in respect of proceedings 'before it' under the Act and
not in respect of proceedings before the Patent Office.
7. The senior counsel for the petitioner contended that we should direct the
Government of India to, in exercise of its rule making power under the Act,
make rules in consonance with the suggestions given in the petition.
8. We are afraid, we cannot do that. The Supreme Court, in V.K. Naswa
Vs. Home Secretary, Union of India (2012) 2 SCC 542 reiterated that the
Court can neither legislate nor issue a direction to the legislature to enact in a
particular manner. It was further reiterated that writ Court, in exercise of its
powers under Article 226, has no power to even indirectly require the
Executive to exercise its law making power. It was held that it is neither legal
nor proper for the High Court to issue direction or advisory sermons to the
Executive in respect of the sphere which is exclusively within the domain of the
Executive under the Constitution. It was yet further held that the Court cannot
assume to itself a supervisory role over the rule making powers of the
Executive. It is not the duty of the Court to enlarge the scope of legislation and
the Court cannot re-write, recast or reframe the legislation. The power to
legislate has not been conferred on the Court. Nor can the Court give any
direction for amending the statutory rules. We ourselves have followed the
same view in Mool Chand Kucheria Vs. Union of India
MANU/DE/1338/2014. Reference in this regard may also be made to P.N.
Kohli Vs. Union of India 177 (2011) DLT 373.
9. Similarly, no directions to the statutory authorities under the Act, to in
exercise of their functions under the Act act contrary to or not in consonance of
the procedure laid down in the Act and the Rules, can be given. We have
recently in Intellectual Property Attorneys Association Vs. Union of India
MANU/DE/2627/2014 held that the Controller General of Patents, Designs and
Trademarks cannot direct the Registrar of Trademarks to exercise his statutory
powers under the Trade Marks Act, 1999 in a particular manner contrary to or
inconsistent with the Act and the Rules. The same applies equally to us.
10. Moreover, the petitioner has sought the relief in vacuum, without
reference to any particular divisional application filed in abuse of Section 16 of
the Act. Though instances of two such abuses have been given but the patent
applicant who had indulged in such abuse has not been made a party to the
petition. It is the settled principle that the Court cannot be approached in
vacuum, without a cause of action. Reference in this regard can be made to our
recent judgment in Federation of Indian Mineral Indsutries Vs. Union of
India MANU/DE/3251/2014. Though the said rule has been diluted in the
context of PILs but the same also does not permit us to deal with a statutory
provision or rule in vacuum, without cause of action.
11. In the circumstances, though we find considerable merit in the grievance
urged by the petitioner as well as in the suggestions made to allay the same, but
find our hands to be tied and accordingly dispose of this petition with a
direction to the respondents to, within a period of six months from today,
treating this writ petition as a representation, take a decision whether any
further amendment in the Patents Rules is necessary to address the malady if
any and if so, to take appropriate steps therefor.
No costs.
RAJIV SAHAI ENDLAW, J
CHIEF JUSTICE
MAY 07, 2015 'pp'
Publish Your Article
Campus Ambassador
Media Partner
Campus Buzz
LatestLaws.com presents: Lexidem Offline Internship Program, 2026
LatestLaws.com presents 'Lexidem Online Internship, 2026', Apply Now!